Wilf Family Cardiovascular Research Institute

Robert E. Michler, M.D.

Robert E. Michler, M.D.Robert E. Michler, M.D.
Professor, Department of Cardiovascular & Thoracic Surgery
Professor, Department of Surgery
Chair, Department of Cardiovascular & Thoracic Surgery
Chair, Department of Surgery
Samuel Belkin Professorial Chair (YU)
Co-Director, Montefiore Einstein Center for Heart and Vascular Care
Associate Professor, Department of Epidemiology & Population Health
Director of Clinical Cardiovascular Research, Department of Medicine 

Dr. Michler is an internationally renowned cardiothoracic surgeon and researcher and leader in several subspecialties, including complex cardiac surgery, heart transplantation, valve repair surgery, ventricular reconstruction for congestive heart failure and minimally invasive cardiac surgery. Of particular note, he was one of the first to perform minimally invasive and robotic surgery in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for mitral valve repair and coronary artery bypass surgery.  full bio>> 


Key Publications

  1. Williams JB, Peterson ED, Brennan JM, Sedrakyan A, Tavris D, Alexander JH, Lopes RD, Dokholyan RS, Zhao Y, O’Brien SM, Michler RE, Thourani VH, Edwards FH, Gross T, Marinac-Dabic D, Smith PK. Endoscopic Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA. 2012;308(5):475-84.
  2. Michler RE, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, Holly TA, Oh JK, Dagenais F, Milano C, Wrobel K, Pirk J, Ali IS, Velazquez EJ, Lee KL, Di Donato M. Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013;146(5):1139-1145.
  3. Michler RE. Surgical Options for the Management of Ischemic Cardiomyopathy.Current Treatment Options in Cardiovascular Medicine. 2013;15(5):518-532.
  4. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D'Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O'Gara PT, Michler RE, Kron IL; the CTSN Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. N Engl J Med. 2014;370(1):23-32.
  5. Michler RE. Stem cell therapy for heart failure. Cardiol Rev. 2014;22(3):105-16.
  6. Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pagé P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, Michler RE; Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178-88.

Funding

  1. 2013-2018
    Network for Cardiothoracic Surgical Investigation in Cardiovascular Medicine
    $5,000,000
    National Institutes of Health (2UM1HL088939)
    Role: Principal Investigator